Zurich Cantonal Bank’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $168M | Buy |
377,013
+23,525
| +7% | +$11M | 0.37% | 40 |
|
|
2025
Q4 | $160M | Sell |
353,488
-34,823
| -9% | -$15M | 0.35% | 38 |
|
|
2025
Q3 | $152M | Sell |
388,311
-6,060
| -2% | -$2.53M | 0.35% | 44 |
|
|
2025
Q2 | $176M | Buy |
394,371
+9,661
| +3% | +$4.45M | 0.43% | 35 |
|
|
2025
Q1 | $187M | Buy |
384,710
+35,233
| +10% | +$16.4M | 0.54% | 26 |
|
|
2024
Q4 | $141M | Buy |
349,477
+29,333
| +9% | +$13.6M | 0.4% | 30 |
|
|
2024
Q3 | $149M | Sell |
320,144
-68,702
| -18% | -$33M | 0.44% | 34 |
|
|
2024
Q2 | $182M | Sell |
388,846
-45,488
| -10% | -$19.7M | 0.59% | 20 |
|
|
2024
Q1 | $182M | Sell |
434,334
-10,853
| -2% | -$4.59M | 0.64% | 22 |
|
|
2023
Q4 | $181M | Buy |
445,187
+18,186
| +4% | +$6.72M | 0.69% | 21 |
|
|
2023
Q3 | $148M | Buy |
427,001
+5,514
| +1% | +$1.93M | 0.66% | 21 |
|
|
2023
Q2 | $148M | Buy |
421,487
+26,496
| +7% | +$8.93M | 0.65% | 22 |
|
|
2023
Q1 | $124M | Buy |
394,991
+10,120
| +3% | +$3.04M | 0.61% | 25 |
|
|
2022
Q4 | $111M | Sell |
384,871
-9,688
| -2% | -$2.95M | 0.59% | 28 |
|
|
2022
Q3 | $114M | Buy |
394,559
+33,449
| +9% | +$9.62M | 0.68% | 22 |
|
|
2022
Q2 | $102M | Buy |
361,110
+74,543
| +26% | +$20M | 0.6% | 24 |
|
|
2022
Q1 | $74.8M | Buy |
286,567
+160,264
| +127% | +$38M | 0.37% | 51 |
|
|
2021
Q4 | $27.7M | Sell |
126,303
-19,306
| -13% | -$3.75M | 0.13% | 139 |
|
|
2021
Q3 | $26.4M | Sell |
145,609
-3,951
| -3% | -$771K | 0.14% | 132 |
|
|
2021
Q2 | $30.2M | Buy |
149,560
+54,229
| +57% | +$11.3M | 0.17% | 116 |
|
|
2021
Q1 | $20.5M | Buy |
95,331
+14,395
| +18% | +$3.16M | 0.12% | 163 |
|
|
2020
Q4 | $19.1M | Buy |
80,936
+8,950
| +12% | +$2.05M | 0.12% | 165 |
|
|
2020
Q3 | $19.6M | Buy |
71,986
+10,418
| +17% | +$2.87M | 0.14% | 135 |
|
|
2020
Q2 | $17.9M | Sell |
61,568
-19,210
| -24% | -$5.21M | 0.15% | 128 |
|
|
2020
Q1 | $19.2M | Buy |
80,778
+20,199
| +33% | +$4.63M | 0.18% | 115 |
|
|
2019
Q4 | $13.3M | Buy |
60,579
+7,604
| +14% | +$1.54M | 0.1% | 220 |
|
|
2019
Q3 | $8.97M | Buy |
52,975
+1,296
| +3% | +$229K | 0.08% | 293 |
|
|
2019
Q2 | $9.48M | Sell |
51,679
-6,800
| -12% | -$1.19M | 0.08% | 274 |
|
|
2019
Q1 | $10.8M | Buy |
58,479
+9,551
| +20% | +$1.76M | 0.1% | 242 |
|
|
2018
Q4 | $8.11M | Sell |
48,928
-74,701
| -60% | -$12.9M | 0.08% | 270 |
|
|
2018
Q3 | $23.8M | Sell |
123,629
-4,470
| -3% | -$796K | 0.2% | 117 |
|
|
2018
Q2 | $21.8M | Sell |
128,099
-3,811
| -3% | -$591K | 0.19% | 116 |
|
|
2018
Q1 | $21.5M | Buy |
131,910
+9,887
| +8% | +$1.61M | 0.2% | 119 |
|
|
2017
Q4 | $18.3M | Buy |
122,023
+28,496
| +30% | +$4.22M | 0.16% | 148 |
|
|
2017
Q3 | $14.2M | Buy |
93,527
+47,134
| +102% | +$7.09M | 0.13% | 181 |
|
|
2017
Q2 | $5.98M | Sell |
46,393
-64
| -0.1% | -$7.7K | 0.06% | 353 |
|
|
2017
Q1 | $5.08M | Buy |
46,457
+2,659
| +6% | +$234K | 0.05% | 393 |
|
|
2016
Q4 | $3.23M | Sell |
43,798
-2,651
| -6% | -$216K | 0.03% | 508 |
|
|
2016
Q3 | $4.05M | Buy |
46,449
+17,746
| +62% | +$1.68M | 0.04% | 445 |
|
|
2016
Q2 | $2.47M | Buy |
28,703
+7,599
| +36% | +$657K | 0.03% | 480 |
|
|
2016
Q1 | $1.68M | Hold |
21,104
| – | – | 0.02% | 588 |
|
|
2015
Q4 | $2.66M | Buy |
21,104
+1,064
| +5% | +$128K | 0.03% | 459 |
|
|
2015
Q3 | $2.09M | Buy |
20,040
+1,863
| +10% | +$239K | 0.03% | 502 |
|
|
2015
Q2 | $2.25M | Sell |
18,177
-234
| -1% | -$29.5K | 0.03% | 491 |
|
|
2015
Q1 | $2.17M | Buy |
18,411
+4,049
| +28% | +$485K | 0.03% | 504 |
|
|
2014
Q4 | $1.71M | Sell |
14,362
-1,972
| -12% | -$222K | 0.05% | 423 |
|
|
2014
Q3 | $1.83M | Sell |
16,334
-85,733
| -84% | -$8.16M | 0.06% | 378 |
|
|
2014
Q2 | $9.66M | Buy |
102,067
+1,445
| +1% | +$101K | 0.28% | 81 |
|
|
2014
Q1 | $7.12M | Buy |
100,622
+6,154
| +7% | +$487K | 0.22% | 101 |
|
|
2013
Q4 | $7.02M | Sell |
94,468
-10,161
| -10% | -$708K | 0.23% | 97 |
|
|
2013
Q3 | $7.93M | Sell |
104,629
-2,638
| -2% | -$210K | 0.27% | 82 |
|
|
2013
Q2 | $8.57M | Buy |
+107,267
| New | +$7.9M | 0.3% | 76 |
|
Other funds holding VRTX
VCM
VPM
Zurich Cantonal Bank's VRTX Position: Q1 2026 in Review
Zurich Cantonal Bank increased its Vertex Pharmaceuticals (VRTX) stake by 6.7% in Q1 2026, buying an estimated $11M and bringing the position to 377,013 shares worth $168M. The position accounts for 0.37% of the portfolio, ranked #40.
Zurich Cantonal Bank first reported a position in VRTX in Q2 2013 and has held it in 52 quarters since. The position peaked at $187M in Q1 2025. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.
- Zurich Cantonal Bank held 377,013 shares of Vertex Pharmaceuticals worth $168M as of Q1 2026.
- Zurich Cantonal Bank bought 23,525 Vertex Pharmaceuticals shares in Q1 2026, an estimated $11M.
- Vertex Pharmaceuticals made up 0.37% of Zurich Cantonal Bank's portfolio in Q1 2026, its #40 holding.
- Zurich Cantonal Bank first reported a position in Vertex Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
- Zurich Cantonal Bank's Vertex Pharmaceuticals position peaked at $187M in Q1 2025.
- 1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.
Based on Zurich Cantonal Bank's 13F filing for Q1 2026, filed 15 May 2026.